Mersana Therapeutics Number of Employees 2016-2022 | MRSN
Mersana Therapeutics number of employees from 2016 to 2022. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Mersana Therapeutics Annual Number of Employees | |
|---|---|
| 2021 | 169 |
| 2020 | 110 |
| 2019 | 83 |
| 2018 | 86 |
| 2017 | 78 |
| 2016 | 68 |
| 2015 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Biomedical and Genetics | $0.432B | $0.000B |
| Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bristol Myers Squibb (BMY) | United States | $166.663B | 10.14 |
| Bio-Rad Laboratories (BIO.B) | United States | $14.121B | 30.63 |
| QIAGEN (QGEN) | Netherlands | $10.600B | 16.73 |
| Biohaven Pharmaceutical Holding (BHVN) | United States | $10.272B | 0.00 |
| Ginkgo Bioworks Holdings (DNA) | United States | $4.442B | 0.00 |
| Arcus Biosciences (RCUS) | United States | $1.751B | 44.38 |
| Emergent Biosolutions (EBS) | United States | $1.534B | 6.57 |
| Myovant Sciences (MYOV) | United Kingdom | $1.224B | 0.00 |
| Zymeworks (ZYME) | Canada | $0.317B | 0.00 |
| Gelesis Holdings (GLS) | United States | $0.111B | 0.00 |
| Ambrx Biopharma (AMAM) | United States | $0.100B | 0.00 |
| Enzo Biochem (ENZ) | United States | $0.097B | 0.00 |
| SQZ Biotechnologies (SQZ) | United States | $0.089B | 0.00 |
| ADC Therapeutics SA (ADCT) | Switzerland | $0.000B | 0.00 |
